The inhibition of the ASM/ceramide pathway by functional ASM inhibitors has beneficial effects on improving neuronal death, neuroinflammation, neurological deficits, and behavioral dysfunction in these neurological disorders. Here, SMPD1 is linked to nervous system disorder.